In Figure  2c, by assuming that the incoming heat energy is positive and the outgoing heat energy is negative, we have (8) Taking into account a system of linear equations for the node (i, j) composed of Equations 2, 7, and 8, the temperature at any mesh node can be obtained. Finally, by substituting the above obtained current density in any mesh segment and temperature at any mesh node into Equation 4, the temperature distribution in any mesh segment can be monitored. A synopsis of the corresponding

computational algorithm [27] is provided as below. Initially, a small value is assigned to the input current I. Cell Cycle inhibitor The corresponding maximum temperature in the mesh T max can be identified, which rises with the increasing I. By gradually increasing I with increment ΔI

to make T max reach T m, the first mesh segment melts and breaks from an arbitrary small force occurring in actual operation (e.g., vibration). At that time, the input current and the voltage between node (0, 0) and node (9, 0) are recorded as melting current Copanlisib molecular weight I m and melting voltage V m. The corresponding resistance R m of the mesh can be calculated by dividing V m by I m. It should be noted that ΔI must be small enough so that melting segment can melt one by one as far as possible. Subsequently, an ultra-small value is assigned to the cross-sectional area of the first melted mesh segment in order to approximate zero. The pathway of the current and heat in the mesh is therefore renewed. By repeating the aforementioned process, the current triggering the melting of mesh segment one by one can be obtained until the mesh becomes open. Therefore, the relationship between I m and V m as well as the variation of R m with the number n b of the broken mesh segments can be obtained Thiamine-diphosphate kinase over the entire melting process of the mesh. Results and discussion

Melting behavior of the Ag microwire mesh As shown in Figure  3a,b, the obtained relationship of melting current I m and melting voltage V m as well as the variation of mesh resistance R m with the number n b of broken mesh segments during the entire melting process of the Ag microwire mesh is compared with those of the corresponding Ag nanowire mesh, respectively. Figure 3 Comparison of melting process for both meshes. (a) The relationship between I m and V m, and (b) the variation of R m with n b . Obviously, a repetitive zigzag pattern is observed in the relationship of I m and V m in the Ag microwire mesh, which demonstrates the repetition of three different trends: increase of both I m and V m, decrease of both I m and V m, and decrease of I m but increase of V m. Such pattern in the melting behavior of Ag microwire mesh is similar with that of the corresponding Ag nanowire mesh [27].

Narici et al. have pointed out that some of this variability may be attributable to differences in the age range between animal groups as well as due to measurement artifacts

associated with clamping of the excised tendons [62]. Human studies of tendon properties have until recently been hindered by requirements for cadaver donors and have been somewhat scarce. To study tendon properties in vivo, a technique has been developed based on longitudinal measurement of tendon deformation by imaging ultrasound during an isometric muscle contraction [63]. Initial studies selleck chemicals llc using this technique compared young and elderly groups, observing that tendons from older subjects were on the order of 15% more compliant [62]. The observation

that the tendons from the young and older subjects had approximately similar dimensions supported the idea that the observed differences could be attributed to differences in mechanical properties. In addition to the observation that older tendons have lower stiffness than tendons from younger subjects, there is also evidence that tendon stiffness can be increased through exercise training [64]. The ability to increase the stiffness of tendons would improve mobility by allowing for faster generation of force on bone, reducing the power and metabolic requirements on Selleckchem MAPK inhibitor skeletal muscle tissue. Narici et al. have presented excellent reviews of the literature on age-related changes in human tendon mechanical properties [62, 65]. Clinical manifestations of sarcopenia With aging, multiple processes occurring within muscle tissue, such as denervation, changes in the hormonal and inflammatory environment, mitochondrial dysfunction, and changes in the expression of regulatory factors affecting the fate of satellite O-methylated flavonoid cells, combine to produce losses in the bulk properties of muscle tissue such as muscle mass and strength. Among the elderly, these changes may eventually result in loss of mobility and independence and increased risk of injury. Loss of muscle

power Age-related loss of skeletal muscle contractile power, which is essential to human motions such as rising from a chair or climbing a flight of stairs, is one of the clinical consequences most commonly linked with sarcopenia. The decline in muscle power has been established in both genders, under multiple loading conditions, in multiple limbs, and in both cross-sectional and longitudinal studies [17]. The most important anatomic sites for muscle function measurement have primarily been in the lower body, as the muscles in these sites are critical for daily function and allow for closest comparison to biopsy data. Further, power and strength losses in the lower limbs confer the largest risk factors for falls and other sources of injury and disability [66, 67]. Lower-limb power and strength are often measured using knee extension and flexion.

4 to .00156 mg ml-1 at 37°C for 1 h. The cells were peletted at 1,000 rpm for 10 min and the supernatant was collected to determine the absorbance at 450 nm using a UV Visible Spectrophotometer (Shimadzu). In negative control sets, erythrocyte suspension and PBS buffer was used whereas in positive controls, lysis buffer was used for completely

lysing the erythrocytes. The percentage haemolysis was calculated and plotted against the concentration of ACP to determine the dose cytotoxic to human erythrocytes. The percentage of intact erythrocytes was calculated using the following formula. Haemagglutination activity assay In view of the findings that dialyzed concentrate exhibits haemagglutination find more activity [72], a serial 2-fold dilution of a solution of ACP (6.4 to 0.0001 mg ml-1) was added in microtitre plates, wherein 100 μl was mixed with 100 μl of a 2.0% suspension of human red blood cells in PBS (pH 7.2) at 20°C. The results were observed after Apoptosis inhibitor about 1 h when the blank without

dialyzed concentrate was fully sedimented to inspect whether the red blood cells had agglutinated in response to the antifungal protein. Amino acid sequencing The corresponding protein band that showed the zone of inhibition against Candida albicans was electro blotted to a 0.45 μm Immobilon-P transfer membrane (Millipore). After blotting at 100 mA for overnight, the membrane was removed carefully from the cassette, washed three times with MilliQ water to remove glycine, and then stained for 30 sec with a freshly prepared solution of 0.1% Coomasie

brilliant blue R-250 in 40% methanol and 1.0% acetic acid. The blot was then destained in 50% methanol until bands were visible and background clear. The PVDF membrane was then dried sandwiched between clean tissue papers. The stained band of interest was tightly cut out and washed six times in MillQ water and subjected to Edman degradation. The N-terminal sequencing selleck chemicals was performed on a Protein sequencer, Model 494 Procise (Applied Biosystems, USA) with 140 C analyzer at Protein Sequencing Facility, IOWA State University, USA. The primary amino acid sequence obtained was entered into BLAST to search for peptides with similar sequences. Mass spectrometry The purified antimicrobial peptide was analyzed by matrix-assisted laser desorption and ionization–time of flight mass spectrometry by using a 4000 Q TRAP Mass Spectrometer (Proteomics International, Nedlands Australia) equipped with an ion source with visualization optics and an N2 laser (337 nm). Protein samples were trypsin digested and peptides extracted according to standard techniques [73]. All digestion reactions were done in 50 mmol NH4HCO3 (pH 8.5) at room temperature and with an enzyme-to-peptide ratio of 1:40 (wt/wt). Peptides were analyzed by electrospray ionisation mass spectrometry using the Ultimate 3000 nano HPLC system [Dionex] coupled to a 4000 Q TRAP mass spectrometer (Applied Biosystems) with a capillary cap voltage of 1,750 V.

SELCO has also supported 110000 rural homes, 2000 institutions, and 10000 small business cottage industries. It has installed over 125000 solar home lighting systems since 1995 (Ashoka and Hystra 2009; SELCO India 2005, 2007, 2011; AYLLU & the CSTS 2011). AuroRE has been successful in delivering affordable, reliable renewable energy products and services to more than 80000 Indians. AuroRE’s projects include installing 1025 solar water pump sets to farmers Selleckchem STA-9090 in 11 Indian states, such as Punjab, providing solar lanterns to street hawkers in Chennai, and coordinating a rural electrification project in

Ladakh using 8700 solar home kits and 6000 lanterns (AuroRE

India 2004; AuroRE 2009). THRIVE’s long-term mission is to disseminate 100 million lights all over the world. Till now, it has benefitted approximately 160000 people, and most of those are poor and tribal people (Ramani 2010; THRIVE 2010). Noble Energy Solar Technologies Ltd. (NEST) had sold around 78800 solar lanterns till 2008, a gradual increase from 12100 back in 2002. The number of lanterns sold currently is around 90000, of which 80 % are sold in India and the rest are exported. KU-57788 concentration NEST is targeting 1 million solar lanterns in 5–6 years under its unique programs such as Solar Seeding to contribute towards NEST’s mission of a kerosene-free world (NEST 2005, 2009; Uppal and Mahendra 2009). D.light Design had sold Fenbendazole 1 million solar lanterns in over 30 countries by the end of February 2010. D.light is targeting 50 million people by 2015 and 100 million people by 2020 (D.light 2010, 2011). Organizational upscaling As far as organizational upscaling is concerned, SELCO has had a successful growth over the last 14 years, with a turnover of around USD 1.75 million in FY 2009 and an estimated turnover of USD

3 million in FY 2010. The company made a loss of INR 7.5 million in 2008–2009, but returned to profit in the financial year 2009–2010, earning INR 3.8 million on a revenue of INR 150 million (Ashoka and Hystra 2009; Mukherji 2011; Pullenkav 2010). SELCO has around 170 employees (four regional sales managers, eight senior managers, 21 branch managers, 32 sales executives, 40 customer support executives, and 18 office administrators, in addition to members of the projects, finance and innovation departments, including senior management). SELCO’s expansion plans include the achievement of an annual turnover of USD 6 million (SELCO 2009; AYLLU & the CSTS 2011). AuroRE has quite different plans for organizational upscaling.

Infect Immun 2005,73(8):4668–4675.PubMedCrossRef 19. Saini S, Slauch JM, Aldridge PD, Rao CV: Role of cross talk in regulating the dynamic expression of the flagellar Salmonella pathogenicity island 1 and type 1 fimbrial genes. J Bacteriol 2010,192(21):5767–5777.PubMedCrossRef

20. Ibarra JA, Knodler LA, Sturdevant DE, Virtaneva K, Carmody AB, Fischer ER, Porcella SF, Steele-Mortimer O: Induction of Salmonella pathogenicity island 1 under different growth conditions can affect Salmonella -host cell interactions in vitro. Microbiology 2010,156(Pt 4):1120–1133.PubMedCrossRef 21. Thijs IM, De Keersmaecker SC, Fadda A, Engelen K, Zhao H, McClelland M, Marchal K, Vanderleyden J: Delineation of the Salmonella enterica serovar Typhimurium HilA regulon through genome-wide location and transcript analysis. J Bacteriol 2007,189(13):4587–4596.PubMedCrossRef 22. Lee CA, Jones BD, Falkow S: Identification BIRB 796 purchase of a Salmonella typhimurium invasion locus by selection for hyperinvasive mutants. Proc Natl Acad Sci USA 1992,89(5):1847–1851.PubMedCrossRef 23. Adaska JM, Silva AJ, Berge AC, CUDC-907 datasheet Sischo

WM: Genetic and phenotypic variability among Salmonella enterica serovar Typhimurium isolates from California dairy cattle and humans. Appl Environ Microbiol 2006,72(10):6632–6637.PubMedCrossRef 24. Bergeron N, Corriveau J, Letellier Nitroxoline A, Daigle F, Quessy S: Characterization of Salmonella Typhimurium isolates associated with septicemia in swine. Can J Vet Res 2010,74(1):11–17.PubMed 25. Dechet AM, Scallan E, Gensheimer K, Hoekstra R, Gunderman-King J, Lockett J, Wrigley D, Chege W, Sobel J: Outbreak of multidrug-resistant Salmonella

enterica serotype Typhimurium Definitive Type 104 infection linked to commercial ground beef, northeastern United States, 2003–2004. Clin Infect Dis 2006,42(6):747–752.PubMedCrossRef 26. Gebreyes WA, Altier C: Molecular characterization of multidrug-resistant Salmonella enterica subsp. enterica serovar Typhimurium isolates from swine. J Clin Microbiol 2002,40(8):2813–2822.PubMedCrossRef 27. Gebreyes WA, Thakur S, Davies PR, Funk JA, Altier C: Trends in antimicrobial resistance, phage types and integrons among Salmonella serotypes from pigs, 1997–2000. J Antimicrob Chemother 2004,53(6):997–1003.PubMedCrossRef 28. Glenn LM, Lindsey RL, Frank JF, Meinersmann RJ, Englen MD, Fedorka-Cray PJ, Frye JG: Analysis of antimicrobial resistance genes detected in multidrug-resistant Salmonella enterica serovar Typhimurium isolated from food animals. Microb Drug Resist 2011,17(3):407–418.PubMedCrossRef 29. Ng LK, Mulvey MR, Martin I, Peters GA, Johnson W: Genetic characterization of antimicrobial resistance in Canadian isolates of Salmonella serovar Typhimurium DT104. Antimicrob Agents Chemother 1999,43(12):3018–3021.PubMed 30.

95 to 3.74 L/h). However, these differences were not statistically different and could have been due to high variability

in individual Ae24h values (range 0.685–12.0%; CV 81.4%) compared with AUC24h on day 5 (range 197–351 ng · h/mL; CV 19.3%). Drug-Drug Interaction with Methotrexate (Study 2) GLPG0259 and methotrexate plasma concentration–time data are plotted in figure 3, and GLPG0259 and methotrexate pharmacokinetic parameters with summary statistical analyses are presented in table IV. Regarding GLPG0259, co-administration of methotrexate 7.5 mg did not significantly alter the rate and extent of absorption of GLPG0259, with point estimates for Cmax and AUC24h of 102.67% and 102.11%, respectively. Although the t1/2,λz of GLPG0259 could be estimated on one occasion only, there was no modification of the elimination, as shown by the superimposable GF120918 chemical structure elimination phases with or without methotrexate in figure 3. It must be noted that even if the study was not powered to analyze the influence Raf inhibitor of methotrexate on GLPG0259 pharmacokinetics, using the 90% CI approach, the intervals were narrow and their boundaries fell within the 80–125% bioequivalence range for both Cmax and AUC24h (table IV). These results are explained by the low/moderate within-subject variability in GLPG0259 pharmacokinetics (<20%) and suggest that

a sample size of 12 subjects would be sufficient to show bioequivalence between two treatments. Table IV Summary statistics for GLPG0259 and methotrexate pharmacokinetic parameters (n = 6) Fig. 3 Mean (± standard error of the mean) plasma concentrations

of (a) GLPG0259 and (b) methotrexate after administration of each drug alone or in combination to fed healthy subjects (n = 6). The plasma pharmacokinetic parameters of methotrexate observed in this study were in agreement with those reported previously for the methotrexate 7.5 mg dose.[14,15] When methotrexate was co-administered with GLPG0259 50 mg, the rate of absorption of methotrexate was slightly but not statistically significantly decreased, with a point estimate for Cmax of 89.63% (figure 3, table IV). The extent of absorption (AUC∞) and the elimination (t1/2,λz) of methotrexate were not affected by GLPG0259, and their point estimates were 118.22% and 110.64%, respectively. Bioavailability and Food Interaction Studies (Studies 1, 3, and 4) As Chloroambucil shown in figure 4a, food did not have an impact on the rate and extent of absorption of GLPG0259 given as 100 mg of free-base oral solution, with a Cmax of 31.8 ng/mL (versus 31.0 ng/mL in the fasted state) and an AUC24h of 562 ng · h/mL (versus 572 ng · h/mL in the fasted state) [table V], and corresponding point estimates of 89.67% (90% CI 74.71, 107.61) and 100.42% (90% CI 83.46, 120.83), respectively (table VI). Table V GLPG0259 pharmacokinetic parameters after a single oral dose of GLPG0259 given as various oral formulations to fasted or fed healthy subjects (n = 6 or 12 per formulation) Table VI Table VI.

Moreover, the CD spectrum of NA-CATH:ATRA1-ATRA1 in SDS was comparable to that of NA-CATH in TFE, suggesting that the alterations made in the sequence of NA-CATH:ATRA1-ATRA1 significantly increased its propensity for forming Poziotinib mouse helical structure. When the peptide sequences are projected on a helical wheel (Figure 4B), the contribution of the substitutions at positions 18 and 25 to a potential hydrophobic face of the NA-CATH:ATRA1-ATRA1 peptide are observed at the top of the helical wheel diagram.

On net, the Ala->Phe and Pro->Leu substitutions at positions 18 and 25, respectively, increase the hydrophobicity at those positions, which may improve the interactions between the peptides and the hydrophobic tails in surfactant micelles (and lipid membranes), further stabilizing helical structure in NA-CATH:ATRA1-ATRA1 when interacting with anionic surfactants or lipids. Similarly, if the

ATRA2 and ATRA1 peptides are projected individually in helical wheel format, the contribution of these two positions can be seen to the potential hydrophobic peptide face of each peptide (Figure 4C). ATRA-1 may present a more helical face that is also significantly more uniform than that of ATRA-2, with the side chain of phenylalanine MLN4924 in vitro at the 3rd position of ATRA-1 exhibiting significantly greater hydrophobic character than the alanine residue at the same position in ATRA-2. Discussion In this study, we tested the in vitro susceptibility of Staphylococcus aureus to an elapid snake-derived cathelicidin, NA-CATH, as well as related novel, synthetic peptides and compared the performance of these peptides to that of the human cathelicidin LL-37. We demonstrated that LL-37 has similar potency in vitro against S. aureus to NA-CATH, as opposed to our earlier findings for E. coli and other Fenbendazole gram-negative bacteria where we determined NA-CATH to be more potent than LL-37 [25, 26]. The EC50 values were

converted from μg/ml to μM to reflect the number of molecules of peptide and to accommodate the different molecular weights of the peptides. Therefore, on a molar basis, LL-37 was slightly (2.4-fold) more effective against S. aureus than the NA-CATH, but the difference was not statistically significant. The EC50 for the D-enantiomer, D-LL-37, was found to be ~10 fold higher than for LL-37, suggesting that it is less effective as an antimicrobial peptide under these conditions for S. aureus. Three 11-residue peptides based on the ATRA motifs of the NA-CATH sequence (ATRA-1, ATRA-2, and ATRA-1A) were compared. The three ATRA peptides all had a nominal charge of +8 at pH 7, and their sequences differed only by the residues at the 3rd (F/A) and 10th position (L/P). On a molar basis, ATRA-1 is significantly more potent against S. aureus than ATRA-2, by ~10-fold.

Tandem mass spectra were extracted and charge state deconvoluted by Proteome Discoverer version 1.4. Charge state deconvolution and deisotoping was not performed. All MS/MS samples were analyzed using Mascot, Sequest (XCorr Only; Thermo Fisher Scientific, San Jose, CA, USA; version 1.3.0.339) and X! Tandem (GPM.org;

version CYCLONE (2010.12.01.1)) assuming digestion with trypsin. A custom E. coli database was generated by combining the fasta files from uniprot.org from the following E. coli strains: 12009/EHEC, 2009EL-2050, 2009EL-2071, Z-DEVD-FMK 2011C-3493, 11128/EHEC, O157:H7, EC4115/EHEC, TW14359/EHEC, and 11368/EHEC. This E. coli fasta file consists of 47,819 entries and was generated in May 2013. Mascot, Sequest (XCorr Only) and X! Tandem were searched with a fragment ion mass tolerance of 0.100 Da and a parent ion tolerance of 10.0 PPM; carbamidomethyl of cysteine and iTRAQ4plex of lysine and the n-terminus were specified as fixed modifications while deamidation of asparagine and glutamine, oxidation of methionine and iTRAQ4plex of tyrosine were specified as variable modifications. Scaffold (version Scaffold_4.0.6) was used to validate MS/MS based peptide and protein identifications,

as described above for ‘Bottom-up Proteomics’. The O157-proteome as expressed in LB was used as the reference against which all the other O157-proteomes were compared. Two biological replicate samples (Sample A and B), corresponding to the duplicate experiments described under ‘Culture conditions, learn more and processing for proteomics’ above, were analyzed separately. In addition, each sample was analyzed twice (Run A and Run B; technical replicates) to cover the entire spectra of proteins in these samples. Only proteins that were consistently identified were selected for analysis. P-type ATPase Statistics and bioinformatics The Student t-Test (two-tailed) was used to evaluate differences between the means of the O157 optical densities and viable counts recovered from the different cultures and a values of p < 0.05 was considered significant. Putative

functions were determined by querying the Conserved Domain Database (CDD) at http://​www.​ncbi.​nlm.​nih.​gov/​Structure/​cdd/​wrpsb.​cgi, and associated metabolic pathways were determined using the KEGG pathway database at http://​www.​genome.​jp/​kegg/​pathway.​html. Cellular and sub-cellular locations of proteins were determined as described previously [17]. Results pH and VFA content The pH and VFA concentrations were comparable amongst all rumen fluid samples, indicating consistency in maintenance diet being fed and the ruminal chemistry between the two animals enrolled in the study (Tables 1 and 2). The pH of the uRF ranged from 6.4-6.7 at collection [28–31] but attained a more neutral pH after filtering, as seen with dRF (pH 7.4–7.9) and fRF (pH, 7.2–7.7) in both experiments (Tables 1 and 2).

Science 323(5911):240–244CrossRef Beloqui A, de María PD, Golyshin PN, Ferrer M (2008) Recent

trends in industrial microbiology. Curr Opin Microbiol 11(3):240–248CrossRef Berkes F, Colding J, Folke C (2003) Navigating social–ecological systems: building resilience for complexity and change. Cambridge University Press, Cambridge Biermann F, Betsill MM, Gupta J, Kanie N, Lebel L, Liverman D, Schroeder H, Siebenhüner B (2009) Earth system governance: people, places and the planet. Earth system governance project report 1. Earth System Governance Project, Bonn Cabral L, Farrington J, Ludi E (2006) The Millennium Villages Project—a new approach to ending rural poverty in Africa? Nat Resour Perspect 101:1–4 Carr ER (2008) The millennium village project and African development: problems and potentials. Prog Dev Stud 8(4):333–344CrossRef Cash DW, Clark WC, Alcock F, Dickson NM, Eckley N, Guston MI-503 price DH, Jäger J, Mitchell RB (2003) Knowledge systems for sustainable development. Proc Natl Acad Sci 100(14):8086–8091CrossRef Checkland P, Scholes J (1990) Soft MAPK inhibitor systems methodology

in action. Wiley, Chichester Chivian E, Bernstein A (2008) Sustaining life: how human health depends on biodiversity. Oxford University Press, USA Clark WC, Dickson NM (2003) Sustainability science: the emerging research program. Proc Natl Acad Sci 100(14):8059–8061CrossRef Costanza R (1997) An introduction to ecological economics. CRC Press, Boca RatonCrossRef Cox RW (1981) Social forces, states and world orders: beyond international relations theory. Millennium 10(2):126–155CrossRef Crutzen PJ (2002) Geology of mankind. Nature 415(January):23 Crutzen PJ, Steffen W (2003) How long have we been in the Anthropocene era. Clim Change 61(3):251–257CrossRef Deutsch CH (2007) A threat so big, academics try collaboration. New York Times, Protirelin New York

Diepeveen S (2008) Putting Empowerment into practice: evaluating the potential for “Development as Freedom” in the Millennium Villages Project. Undercurr J 5(1):6–13 Dirzo R, Raven PH (2003) Global state of biodiversity and loss. Ann Rev Environ Resour 28(1):137–167CrossRef Dobson A (2003) Citizenship and the environment. Oxford University Press, OxfordCrossRef Dryzek JS (1997) The politics of the earth. Environmental discourses. Oxford University Press, Oxford Eckersley R (2004) The green state. Rethinking democracy and sovereignty. MIT Press, Cambridge Eikenberry AM, Kluver JD (2004) The marketization of the nonprofit sector. Civil society at risk? Public Admin Rev 64(2):132–140CrossRef Ferrer-Balas D, Lozano R, Huisingh D, Buckland H, Ysern P, Zilahy G (2010) Going beyond the rhetoric: system-wide changes in universities for sustainable societies. J Cleaner Prod 18(7):607–610CrossRef Feyerabend PK (1991) Three dialogues on knowledge.

Under illumination, Trichostatin A the electrons and holes are generated in the SCNT film and the Si substrate. They are collected by the built-in voltage V d at the junction, where holes and electrons are directed to the SCNT film and the n-Si substrate, respectively. Thus, the formation of the charge accumulation layer on both the sides can reduce the built-in potential, and the reduced potential is equal to the V OC. Thereby, the V OC depends on the built-in potential height of the junction V d. Thus, the higher built-in potential height generates the higher V OC under illumination, which can

increase the power conversion efficiency of the cell. Figure 6 Energy band diagram of the SCNT/n-Si heterojunction solar cell. Dashed-dotted red line, hν; blue circle, electron. In order to better understand the effect of Au doping on the carrier selleck products density and mobility of the SCNT, Hall effect measurements were performed for the SCNT film deposited on a glass substrate at room temperature. The Hall effect measurements revealed that the SCNT networks were all p-types conductivity before and after Au doping. After doping,

an average carrier density for the SCNT film increased from 5.3 × 1018 to 1.4 × 1020 cm−3. This enhanced carrier density is advantageous for SCNT/n-Si photovoltaic devices because p doping and the reduced resistivity are in favor of charge collection and preventing carriers from recombination. The gold-hybridization SCNT can provide more charge transport paths, resulting in improved cell PCE Amrubicin more than three folds. Recent studies

showed that doping also decreased the tunneling barrier between SCNT and concluded that this is the major fact in the overall film resistance [45–47]. So the devices series resistance (Rs) dropped from 218 Ω (or 8.72 Ω·cm2) in the SCNT/Si cell to 146 Ω (or 5.84 Ω·cm2) in the gold-hybridization SCNT-Si cell. The effect of the immersion time of SCNT in HAuCl4·H2O solution on the photovoltaic characteristics of the device was investigated. The relative data are shown in the Table 1. It can be seen that with increasing immersion time, the PCE increases. But if the immersion time is too long, the efficiency of the device decreases, although the increasing absorbs of light increases (Figure 5b). Larger particles along with larger surface coverage lead to increased parasitic absorption and reflection, reducing the desired optical absorption in SCNT film layer [48]. In addition, the particles embedded between SCNT and Si substrate will reduce the density of p-n junction and lead to a significantly decrease shunt resistance; therefore, the J SC and P CE decrease. This means that too many Au nanoparticles and very large particles covering on the SCNT will reduce their device PCE.